Wordt geladen...
miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2
Because cutaneous melanoma (CM) is one of the most lethal human tumors, major treatment advances are vital. miR-140-3p has been suggested to act as a suppressor in a range of malignant tumors, implying its possible use as a biomarker for effective antineoplastic treatment. However, the potential rol...
Bewaard in:
| Gepubliceerd in: | Mol Ther Oncolytics |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Gene & Cell Therapy
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7163049/ https://ncbi.nlm.nih.gov/pubmed/32322665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.03.009 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|